Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Hanmi presents promising results for HM-71224

July 14, 2014

Celgene reports data from phase III POSTURE study

July 10, 2014

Once-daily tofacitinib shows bioequivalence for the immediate-release formulation

July 9, 2014

Researchers at Roche and Genentech divulge novel RORC modulators for arthritis

July 8, 2014

TiGenix to develop allogeneic stem cell therapy for early RA and sepsis

July 2, 2014

Novel chimeric fusion protein reduces arthritis in a mouse model

July 1, 2014

Sirukumab shows a negative risk/benefit profile for active lupus nephritis

July 1, 2014

Data reported on ABT-981 in healthy subjects and patients with knee osteoarthritis

June 30, 2014

Aurinia initiates phase IIb trial of voclosporin in lupus nephritis

June 27, 2014

Nandrolone decanoate/vitamin D3 fixed-dose combination evaluated in multiple doses

June 27, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...